Join Us

We are 224,435 members in 83 forums discussing 163,550 topics.

Help with Abbreviations

Topic: Oncotype DX Less Accurate in Certain Early-Stage Black Women

Forum: Black Women or Men With Breast Cancer —

Black Women with Breast Cancer who want to connect.

Posted on: Feb 2, 2021 06:01PM

Moderators wrote:

Oncotype DX Results Appear Less Accurate in Black Women Diagnosed With Certain Early-Stage Breast Cancers
January 29, 2021

Black women diagnosed with stage I to stage III estrogen-receptor-positive, axillary node-negative breast cancer were more likely to die from breast cancer than white women with similar diagnoses and similar Oncotype DX Breast Recurrence Scores. Read more...

To send a Private Message to the Mods:
Log in to post a reply

Page 1 of 1 (1 results)

Posts 1 (1 total)

Log in to post a reply

Feb 18, 2021 08:11AM - edited Feb 18, 2021 08:49AM by Jinx27

Interesting article, I remember asking my MO for a Oncotype DX or Mammaprint test and they told me that there weren't many women my (under 40) age who participated the study, they also probably knew the study had a very small representation for Black BC patients. So I never had one done.

Diagnosed at 27 y/o, synchronous bilateral breast cancer. L. Breast : IDC, R. Breast: DCIS. ER 98%, PR 100% Possible mutation. 5-10 yrs hormonal therapy 08/31/2016 Tamoxifen, 02/01/2017- 06/10/2021 AI + OS,Tamoxifen 08/10/2021 -current Dx 9/8/2015, DCIS/IDC, Both breasts, 4cm, Stage IIB, Grade 3, 3/36 nodes, ER+/PR+, HER2- Surgery 11/17/2015 Reconstruction (left): Free TRAM flap; Reconstruction (right): Free TRAM flap Chemotherapy 1/1/2016 AC + T (Taxol) Hormonal Therapy 8/28/2016 Arimidex (anastrozole), Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone), Zoladex (goserelin)

Page 1 of 1 (1 results)